Live Pharmacy Next Expert Panel Predicts the Future of Drug Safety, Affordability and Personalization | Company

–(BUSINESS WIRE)–November 2, 2022–

Wolters Kluwer (AEX:WKL):

What:Pharmacy Next: safer, affordable and personalizedan online panel hosted by Wolters Kluwer of medical, retail pharmacy and pharmacogenomics experts who predict the future of prescription drugs and pharmacy as healthcare delivery decentralizes across the continuum of care .

The panel will discuss the patient safety risks emerging with prescription drugs in tomorrow’s more distributed models of care, whether patient trust and outcomes will improve as prescriber roles are changing and how healthcare consumer drug costs can be contained. Additionally, as innovative precision drugs spread, are Americans open to pharmacogenomic testing to pair them with more personalized treatments based on their individual genetics?

Pharmacy Next panelists will also discuss the surprising results of a new consumer survey from Wolters Kluwer this foreshadows massive shifts in Americans’ confidence in prescribing drugs, concerns, as well as the trade-offs consumers are willing to accept for lower drug costs.

When: Thursday, November 3, 2022 at 11 a.m. EDT

Where: This is a live online event with Q&A for attendees. Registration is free and accessible here. Attendees who join the live event will be the first to receive a summary of the news Pharmacy Next consumer survey followed by an in-depth report in January 2023.

Who:Peter Bonis, MDChief Medical Officer at Wolters Kluwer, will present the Pharmacy Next panel. Daniel Streetman, Doctor of Pharmacyfrom the Metabolism, Interactions and Genomics group at Wolters Kluwer, will lead the discussion.

Pharmacy Next panelists include:

  • David Bates, MD, internationally renowned patient safety expert from Brigham and Women’s Hospital and Harvard Medical School
  • Daniel Knecht, MD, Vice President and Director of Clinical Innovation at CVS Caremark
  • Jill Kolesar, PharmD, expert in pharmacy practice and precision medicine from the University of Kentucky School of Pharmacy

Register to watch the live Pharmacy Next panel here.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions and services for clinicians, nurses, accountants, lawyers and tax, finance, auditing, risk, compliance and regulation. We help our customers make critical decisions every day by delivering expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer achieved annual sales of €4.8 billion in 2021. The group serves customers in over 180 countries, maintains operations in over 40 countries and employs approximately 19,800 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes in healthcare. We support clinical efficiency, learning and research, clinical monitoring and compliance, and data solutions. For more information on our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.comfollow us on Twitter, Facebook, LinkedInand Youtube.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20221012005303/en/

CONTACT: Media

Andre Rebelo

Deputy Director of Public Affairs and Public Relations

Wolters Kluwer

+1 (781) 392-2411

[email protected]

KEYWORD: NETHERLANDS EUROPE

INDUSTRY KEYWORD: TECHNOLOGICAL RESEARCH TECHNOLOGY HEALTH SOFTWARE OTHER HEALTH SCIENCE OF PHARMACEUTICAL DATA MANAGEMENT HEALTH

SOURCE: Wolters Kluwer Health

Copyright BusinessWire 2022.

PUBLISHED: 02/11/2022 06:01 AM/DISC: 02/11/2022 06:02 AM

http://www.businesswire.com/news/home/20221012005303/en

Copyright BusinessWire 2022.

Comments are closed.